Inventor · disambiguated record
Sanjay K. Phogat
Also filed as: PHOGAT SANJAY · PHOGAT SANJAY K
25 granted patents·10 pending applications·88 citations·filing 2002–2025
95Inventor score
Files withTHERACLONE SCIENCES INC12INT AIDS VACCINE INITIATIVE7INT AIDS VACCINE INITIATIVE INC3KOFF WAYNE C2PHOGAT SANJAY K2
Top patents by PatentIndex Score
35 records- 0196US12410243B2Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodiesINT AIDS VACCINE INITIATIVE INC·Filed 2023·Granted Sep 9, 2025·2 cites·16 claims
- 0296US10087239B2Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodyTHERACLONE SCIENCES INC·Filed 2016·Granted Oct 2, 2018·14 cites·7 claims
- 0395US9464131B2Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodyTHERACLONE SCIENCES INC·Filed 2013·Granted Oct 11, 2016·18 cites·4 claims
- 0492US9051362B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityCHAN-HUI PO-YING·Filed 2010·Granted Jun 9, 2015·14 cites·20 claims
- 0591US12312396B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2024·Granted May 27, 2025·0 cites·32 claims
- 0691US11319362B2Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodiesTHERACLONE SCIENCES INC·Filed 2019·Granted May 3, 2022·3 cites·44 claims
- 0786US12018067B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2023·Granted Jun 25, 2024·0 cites·29 claims
- 0885US10865234B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2019·Granted Dec 15, 2020·1 cites·7 claims
- 0985US8586056B2HIV-1 envelope glycoproteinPHOGAT SANJAY K·Filed 2011·Granted Nov 19, 2013·14 cites·8 claims
- 1083US10836811B2Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodyTHERACLONE SCIENCES INC·Filed 2017·Granted Nov 17, 2020·1 cites·4 claims
- 1181US10407493B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2019·Granted Sep 10, 2019·1 cites·20 claims
- 1280US7223844B2Broadly cross-reactive neutralizing antibodies against human immunodeficiency virus selected by Env-CD4-co-receptor complexesSCRIPPS RESEARCH INST·Filed 2002·Granted May 29, 2007·16 cites·27 claims
- 1379US11845789B2Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodiesTHERACLONE SCIENCES INC·Filed 2021·Granted Dec 19, 2023·0 cites·15 claims
- 1478US7378093B2Broadly cross-reactive neutralizing antibodies against Human Immunodeficiency Virus selected by Env-CD4-co-receptor complexesUS HEALTH·Filed 2007·Granted May 27, 2008·3 cites·15 claims
- 1578US2025320281A1Methods of treating hiv-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (hiv-1) gp120-specific monoclonal antibodiesINT AIDS VACCINE INITIATIVE INC·Filed 2025·Application pending·0 cites
- 1676US11584789B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2020·Granted Feb 21, 2023·0 cites·31 claims
- 1774US10844095B2Recombinant viral vectorsINT AIDS VACCINE INITIATIVE·Filed 2019·Granted Nov 24, 2020·0 cites·7 claims
- 1874US8105600B2Method of inducing high-titer neutralizing antibody responses in a host by administering immune complexes comprising anti-HIV-1 Env antibodies and the HIV-1 EnvKOFF WAYNE C·Filed 2008·Granted Jan 31, 2012·1 cites·8 claims
- 1973US11891416B2Recombinant viral vectorsINT AIDS VACCINE INITIATIVE INC·Filed 2020·Granted Feb 6, 2024·0 cites·9 claims
- 2069US10239934B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2018·Granted Mar 26, 2019·0 cites·14 claims
- 2163US10202424B2Recombinant viral vectorsINT AIDS VACCINE INITIATIVE·Filed 2017·Granted Feb 12, 2019·0 cites·11 claims
- 2263US9802986B2Recombinant viral vectorsINT AIDS VACCINE INITIATIVE·Filed 2015·Granted Oct 31, 2017·0 cites·8 claims
- 2363US2025345407A1Nucleic acid based vaccine encoding an escherichia coli fimh antigenic polypeptideCureVac SE·Filed 2023·Application pending·0 cites
- 2460US9920111B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2015·Granted Mar 20, 2018·0 cites·8 claims
- 2560US9382311B2HIV-1 broadly neutralizing antibodiesINT AIDS VACCINE INITIATIVE·Filed 2013·Granted Jul 5, 2016·0 cites·8 claims
- 2659US9796774B2HIV-1 broadly neutralizing antibodiesINT AIDS VACCINE INITIATIVE·Filed 2016·Granted Oct 24, 2017·0 cites·5 claims
- 2759US2010215691A1Recombinant viral vectorsPARKS CHRISTOPHER L·Filed 2010·Application pending·0 cites
- 2852US2008267989A1Hiv Gp-41-Membrane Proximal Region Arrayed On Hepatitis B Surface Antigen Particles as Novel AntigensUS GOV HEALTH & HUMAN SERV·Filed 2006·Application pending·0 cites
- 2950US9610346B2Recombinant viral vectorsINT AIDS VACCINE INITIATIVE·Filed 2013·Granted Apr 4, 2017·0 cites·7 claims
- 3050US2024115688A1Novel AntigensGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2021·Application pending·0 cites
- 3149US2012258124A1Antigen-antibody complexes as hiv-1 vaccinesKOFF WAYNE C·Filed 2012·Application pending·0 cites
- 3247US2015065381A1Methods of identifying novel hiv-1 immunogensINT AIDS VACCINE INITIATIVE·Filed 2014·Application pending·0 cites
- 3345US2005106160A1Hiv-1 envelope glycoproteins stabilized by flexible linkers as potent entry inhibitors and immunogensFiled 2002·Application pending·0 cites
- 3437US2011217338A1HIV-1 Envelope Based FragmentsPHOGAT SANJAY K·Filed 2011·Application pending·0 cites
- 3535US2011123556A1Immunogen prioritization for vaccine designPHOGAT SANJAY·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sanjay K. Phogat files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →